EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   2.4.1.87 | 4 UDP-alpha-D-galactose + Galbeta(1-4)GlcNAcbeta(1-3)(Galbeta(1-4)GlcNAcbeta(1-6))Galbeta(1-4)GlcNAcbeta(1-3)[Galbeta(1-4)GlcNAcbeta(1-3)(Galbeta(1-4)GlcNAc(1-6)Galbeta(1-4)GlcNAcbeta(1-6))]Galbeta(1-4)GlcNAc |
- |
Bos taurus |
4 UDP + Galalpha(1-3)Galbeta(1-4)GlcNAcbeta(1-3)(Galalpha(1-3)Galbeta(1-4)GlcNAcbeta(1-6))Galbeta(1-4)GlcNAcbeta(1-3)[Galalpha(1-3)Galbeta(1-4)GlcNAcbeta(1-3)(Galalpha(1-3)Galbeta(1-4)GlcNAc(1-6))Galbeta(1-4)GlcNAcbeta(1-6)]Galbeta(1-4)GlcNAc |
- |
? |
| 2.4.1.87 | more |
- |
Bos taurus |
? |
- |
? |
| 2.4.1.87 | more |
acceptor substrate specificity |
Mus musculus |
? |
- |
? |
| 2.4.1.87 | more |
acceptor substrate specificity |
Bos taurus |
? |
- |
? |
| 2.4.1.87 | more |
product analysis with H-NMR spectroscopy |
Bos taurus |
? |
- |
? |
| 2.4.1.87 | more |
specificity, most active acceptors have the structure beta-D-Gal-(1-4)-beta-D-GlcNAc(1-4) at their nonreducing termini |
Mus musculus |
? |
- |
? |
| 2.4.1.87 | more |
the alphaGal(1-3)Gal epitope is the major xenoantigen responsible for the hyperacute vascular rejection occurring in pig-to-primate organ transplantation |
Sus scrofa |
? |
- |
? |
| 2.4.1.87 | more |
synthesis of Ehrlich ascites tumor cell glycoproteins |
Mus musculus |
? |
- |
? |
| 2.4.1.87 | more |
functions in the biosynthesis of cell surface polylactosaminoglycans on Novikoff cells, attachs a galactose to the N-acetylglucosaminyl residue introduced by EC 2.4.1.149 |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.87 | more |
functions in the biosynthesis of calf thymocyte cell-surface glycoconjugates including glycoproteins |
Bos taurus |
? |
- |
? |
